Food and Drug Administration approves lofexidine (Lucem...
October 1, 2019 - Featured , In the News / Politics By: Evanthia Siozios, PharmD Candidate c/o 2020 Anxiety, nausea, muscle pain, insomnia are some of the most common withdrawal symptoms experienced when users stop taking opioids. According to a randomized controlled trial entitled Prescription Opioid Addiction Treatment Study (POATS) conducted in outpatient treatment settings across the United States including Mclean Hospital in Massachusetts and… |
|
Residency Starter Guide...
October 1, 2019 - Featured , Professional Advice / Opinions By: Yao Jiang, PharmD (St. John’s University c/o 2019) “Do you want to do a residency?” a senior pharmacy student asked me as I strolled past their booth on Pharmacy Organization Day during my first year of pharmacy school. I stopped for a minute, but everything they said about post graduate training and clinical… |
|
The rising cost of insulin...
October 1, 2019 - Featured , In the News / Politics By: Daniela Farzadfar, PharmD Candidate c/o 2020 Over 30 million Americans are currently living with diabetes. According to the American Diabetes Association (ADA), in 2017, the total cost of diagnosed diabetes in the United States was 327 billion dollars with 237 billion dollars alone attributed to direct medical costs.1 Among these direct medical costs… |